| Pts | Age (y) | DLI dose per infusion (CD3 + cells/kg) | Blina Dose | # Blina + DLI | # DLI Alone | Best response | End of treatment Chimerism % |
FU from post -SCT MRD + (weeks) | Status |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 17 | 5x106/kg | 15 mcg/m2/kg/28 days | 4 | 3 (pre Blina-DLI) | MRD - CR | 100 | 28 | CNS relapse |
| 2 | 16 | 6x106/kg | 15 mcg/m2/kg/28 days | 1 | 3 (Post Blina-DLI) | MRD - CR | 100 | 8 | CR |
| 3 | 3 | 5x106/kg | 15 mcg/m2/kg/28 days | 3 | 3 (Pre Blina-DLI) | MRD - CR | 100 | 44 |
CNS relapse |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.